Translate Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber/Boston Children’s assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a medical interpreter for a discussion about your care.
Displaying 11-20 of 71 results matching:
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center #1 in the nation in its 2022-23 Best Children's Hospitals report.
Children with high-risk neuroblastoma had worse outcomes if they were from certain racial/ethnic groups or were on public rather than private insurance, despite being treated in clinical trials with standardized protocols, according to a study led by investigators from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center.
2022 Canada Gairdner Award given to Stuart H. Orkin, MD, researcher at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center was ranked as one of 15 transplant centers in the country that performed above the expected survival rate
Dana-Farber/Boston Children’s faculty named 2022 Top Doctors by Boston Magazine
The U.S. Food and Drug Administration today approved a treatment to prevent acute graft-versus-host disease (GVHD) in patients 2 years of age or older receiving a hematopoietic stem cell transplant from a matched or single-HLA-mismatched unrelated donor.
The Dana-Farber/Boston Children’s Cancer and Blood Disorders Center has launched a fully redesigned website designed to be user-friendly and intuitive.
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #2 in the nation in its 2021-22 Best Children's Hospitals report.
A. Thomas Look, MD, of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, has been awarded the 2021 Society of Memorial Sloan Kettering Prize. The award was presented to Look at the Gerstner Sloan Kettering (GSK) virtual convocation on May 19, 2021.
The grant was given to Leonard Zon, MD, of Boston Children’s Hospital who will collaborate extensively with other scientists at Boston Children’s Hospital and Dana-Farber Cancer Institute, including Scott A. Armstrong, MD, PhD; Vijay G. Sankaran, MD, PhD; Fernando Camargo, PhD; and Serine Avagyan, MD, PhD.